Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
Disease Modification Concepts in Atopic Dermatitis

Disease Modification Concepts in Atopic Dermatitis

The soundbite recording captures Dr. Ramien's discussion of disease modification concepts in atopic dermatitis, exploring current understanding and approaches to altering disease progression.

Can Early Intervention Shape the Course of Atopic Dermatitis

Can Early Intervention Shape the Course of Atopic Dermatitis

The soundbite recording captures Dr. Paller's discussion examining whether early therapeutic intervention can influence the natural course of atopic dermatitis. The presentation explores the potential for timely treatment approaches to modify disease trajectory.

Atopic Dermatitis in Children: High Burden and Limited Treatment Options

Atopic Dermatitis in Children: High Burden and Limited Treatment Options

This educational video examines the prevalence of moderate and severe atopic dermatitis in children, presenting data that describes the significant disease burden and its impact on both pediatric patients and their families. The content explores current challenges in achieving optimal disease control in children with moderate and severe atopic dermatitis, providing healthcare professionals with evidence-based insights into the clinical management complexities of this patient population.

1. Đại Cương Về Miễn Dịch Học

1. Đại Cương Về Miễn Dịch Học

2. Tiêm Chủng Cho Mọi Lứa Tuổi

2. Tiêm Chủng Cho Mọi Lứa Tuổi

3. Khám Sàng Lọc Và Kỹ Năng Tư Vấn Chủng Ngừa

3. Khám Sàng Lọc Và Kỹ Năng Tư Vấn Chủng Ngừa

한국 신생아 및 영아에서 RSV 감염 예방을 위한 니르세비맙의 경제적 타당성 분석

한국 신생아 및 영아에서 RSV 감염 예방을 위한 니르세비맙의 경제적 타당성 분석

Analysis of the economically justifiable price of nirsevimab to prevent respiratory syncytial virus infection in Korea.
Hyun Jin Han, Semin Jang, Dahye Ryu, Haeseon Lee, Jiyeon Lee, Eun Jin Bae, Samira Soudani, Hae Sun Suh.

BOLETÍN EPIDEMIOLÓGICO REGIONAL N° 2: Actualizado hasta la semana 39 de 2025

BOLETÍN EPIDEMIOLÓGICO REGIONAL N° 2: Actualizado hasta la semana 39 de 2025

KEVZARA® - bei RHEUMATOIDER ARTHRITIS (RA)

KEVZARA® - bei RHEUMATOIDER ARTHRITIS (RA)

KEVZARA® - Service

KEVZARA® - Service

Type 2 inflammation and CRSwNP Video

Type 2 inflammation and CRSwNP Video

Virtual COPD Collaborative Care: Case Studies and Best Practices​

Virtual COPD Collaborative Care: Case Studies and Best Practices​

Watch now to gain clinical insights from real clinical cases in COPD management.​